rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Chas McKhann

Director

Company insider

Files Form 4 as: Director, Exagen; Director, Envoy Medical; Chief Executive Officer, Silk Road Medical; President and CEO, Apollo Endosurgery; Chief Commercial Officer, Intersect ENT.

In numbers

Trades disclosed
25
Buys
0
Sells
6
Bought
$0
Sold
$1.0M
Companies
5
Companies where not an officer
2
First trade
2 Feb 2015
Last trade
9 Jun 2026
Last filed
22 Jun 2026

Companies traded

Where they are an officer
Silk Road MedicalDirector, Officer · last 17 Sep 20240 buys · 0 sells
Apollo EndosurgeryDirector, Officer · last 4 Apr 20230 buys · 6 sells
Intersect ENTOfficer · last 15 Jan 20160 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
XGN ExagenDirector · Diagnostics & Labs · last 9 Jun 20260 buys · 0 sells
COCH Envoy MedicalDirector · Medical Devices · last 15 Apr 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 22 Jun 2026XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—37,500 at $0.00filing
9 Jun 2026filed 22 Jun 2026XGN Exagenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—37,500 at $0.00filing
15 Apr 2026filed 17 Apr 2026COCH Envoy Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A—100,000 at $0.00filing
15 Apr 2026filed 17 Apr 2026COCH Envoy Medicaloption or derivative · Medical DevicesSEC FORM 4 Code A—100,000 at $0.00filing
17 Sep 2024filed 18 Sep 2024Silk Road MedicalSEC FORM 4 Code D—722,396filing
17 Sep 2024filed 18 Sep 2024Silk Road MedicalSEC FORM 4 Code A—1,299,042 at $0.00filing
17 Sep 2024filed 18 Sep 2024Silk Road MedicalSEC FORM 4 Code D—1,299,042filing
1 Mar 2024filed 5 Mar 2024Silk Road MedicalSEC FORM 4 Code A—110,313 at $0.00filing
2 Nov 2023filed 3 Nov 2023Silk Road MedicalSEC FORM 4 Code A—612,083 at $0.00filing
4 Apr 2023filed 4 Apr 2023Apollo Endosurgeryoption or derivativeSEC FORM 4 Code D—848,733filing
4 Apr 2023filed 4 Apr 2023Apollo Endosurgeryoption or derivativeSEC FORM 4 Code D—459,170filing
4 Apr 2023filed 4 Apr 2023Apollo EndosurgerySEC FORM 4 Code D—689,880filing
14 Jun 2022filed 16 Jun 2022Apollo Endosurgeryoption or derivativeSEC FORM 4 Code A—459,170 at $0.00filing
14 Jun 2022filed 16 Jun 2022Apollo EndosurgerySEC FORM 4 Code A—112,607 at $0.00filing
5 May 2022filed 9 May 2022Apollo EndosurgerySEC FORM 4 Code F$361K66,553 at $5.42filing
20 Aug 2021filed 20 Aug 2021Apollo EndosurgerySEC FORM 4 Sold$164K21,148 at $7.74filing
20 Aug 2021filed 20 Aug 2021Apollo EndosurgerySEC FORM 4 Sold$164K21,148 at $7.74filing
19 Aug 2021filed 20 Aug 2021Apollo EndosurgerySEC FORM 4 Sold$167K21,148 at $7.89filing
19 Aug 2021filed 20 Aug 2021Apollo EndosurgerySEC FORM 4 Sold$167K21,148 at $7.89filing
18 Aug 2021filed 20 Aug 2021Apollo EndosurgerySEC FORM 4 Sold$174K21,156 at $8.21filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed6

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.